Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 24
2006 23
2007 25
2008 35
2009 76
2010 95
2011 114
2012 123
2013 125
2014 179
2015 155
2016 228
2017 223
2018 308
2019 475
2020 548
2021 515
2022 459
2023 456
2024 146

Text availability

Article attribute

Article type

Publication date

Search Results

2,596 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of oncology infusion pharmacy practices: A nationwide survey.
Boyd AM, Sue C, Khandoobhai A, Vinson B, Shaikh H, Sorenson S, Patel V, Snyder B, Bondarenka C, Koukounas Y, Earl M, Jenkins M. Boyd AM, et al. J Oncol Pharm Pract. 2024 Jan;30(1):127-141. doi: 10.1177/10781552231170358. Epub 2023 Apr 25. J Oncol Pharm Pract. 2024. PMID: 37122190
Pembrolizumab-induced agranulocytosis.
Fernández Martínez V, García-Avello Fernández-Cueto A, Valencia Soto CM, Barbadillo Villanueva S, Ochagavía Sufrategui M, Rioja Carrera M, Alonso Buznego LA, Valero Domínguez M. Fernández Martínez V, et al. J Oncol Pharm Pract. 2024 Jan 30:10781552241228774. doi: 10.1177/10781552241228774. Online ahead of print. J Oncol Pharm Pract. 2024. PMID: 38291678
Combined use of pembrolizumab and lenvatinib: A review.
Eisinger C, Muluneh B. Eisinger C, et al. J Oncol Pharm Pract. 2023 Sep;29(6):1461-1466. doi: 10.1177/10781552231178461. Epub 2023 May 25. J Oncol Pharm Pract. 2023. PMID: 37231712 Free PMC article. Review.
2,596 results